High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Fred Hutchinson Cancer Center
- Study ID
- NCT06298734
- Status
- Recruiting
Conditions
- Advanced Melanoma
- Melanoma (Skin)
- Skin Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Exercise Program — BEHAVIORALA high-intensity interval training, aerobic exercise program virtually supervised, home-based, and appointment-based program under direct one-on-one supervision by a trained oncology exercise specialist. Sessions will be conducted via the Zoom platform. Participants will be provided with home stationary bike, heart rate monitor, blood pressure monitor. For participants who do not have a smart device, a Wi-Fi enabled tablet will be provided.
- Diet Program — BEHAVIORALA virtual dietary consultation program supervised by trained research staff. Appointments will be conducted via the Zoom platform. Participants will receive an education handout at the baseline visit.
Study Details
The purpose of this study is to determine whether high-intensity exercise and high-fiber diet are feasible and improve various health outcomes among participants with advanced melanoma receiving immunotherapy. The names of the groups in this research study are: * High-Intensity Exercise (EX) * High-fiber Diet (DT) * Combined High-Intensity Exercise and High-Fiber Diet (COMB) * Attention Control (AC)
Key Dates
- Start date
- Jul 1, 2024
- Status verified
- Mar 2026
- Primary completion
- Jul 31, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Group A: High-Intensity Exercise (EX)10 participants will complete: * In-office baseline visit. * Virtual exercise sessions 3x weekly. * Post-intervention in-office visit.
- Experimental: Group B: High-Fiber Diet (DT)10 participants will complete: * In-office baseline visit. * 1x weekly appointment with research staff to review to review diet adherence. * Post-intervention in-office visit.
- Experimental: Group C: Combined High-Intensity Exercise and High-fiber Diet (COMB)10 participants will complete: * In-office baseline visit. * Virtual exercise sessions 3x weekly. * 1x weekly appointment with research staff via Zoom platform to review to review diet adherence. Diet appointment may be combined with exercise session appointment. * Post-intervention in-office visit.
- No Intervention: Group D: Attention Control (AC)10 participants will complete: * In-office baseline visit. * Participants will receive a general healthy lifestyle guidebook. * Pot-intervention in-office visit.
Primary Outcome Measure
Proportion of Participants Completing the Intervention Sessions [ Time Frame: Post-intervention (Week 10) ]
Central Contacts
- Dong-Woo Kang, PhD206-667-5188
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | Christina Dieli-Conwright, PhD (PRINCIPAL_INVESTIGATOR) |
| Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington | 98109 | Dong-Woo Kang, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
By condition
By specialty
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer SurgeryEnrolling By Invitation · Memorial Sloan Kettering Cancer Center · Sacramento, California
- Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)PHASE3 · Recruiting · Immunocore Ltd · Phoenix, Arizona
- Cryoablation+Ipilimumab+Nivolumab in MelanomaPHASE2 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts